GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: AZD 9056 | AZD-9056
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: AZD9056 is a potent, selective, orally bioavailable P2X7 receptor antagonist. This compound was in the AstraZeneca/NCATS repurposing list from 2012. | 
 | |||||||||||||||||||||||||||||||||||
| Immunopharmacology Disease | |||
| Disease | X-Refs | Comment | References | 
| Rheumatoid arthritis | Disease Ontology: 
                                                                        DOID:7148 OMIM: 180300 | Reached Phase 2 clinical evaluation in RA, but development was discontinued. | |
| Crohn's disease | Disease Ontology: 
                                                                        DOID:8778 OMIM: 266600 Orphanet: ORPHA206 | Developed with potential for treating CD, but development was discontinued. | |
| Chronic obstructive pulmonary disease | Disease Ontology: 
                                                                        DOID:3083 | Developed with potential for treating COPD, but development was discontinued. | |